Korean Market
EXCH
ADBIOTECH
★

Derivative Valuation Loss Occurred

 
PERI
ADBIOTECH
★★★

ADBIOTECH Posts Q1 Consolidated Operating Loss of 1.06B Won and Net Loss of 5.4B Won, Impacted by CB Valuation Losses

 
MATR
ADBIOTECH
★

Adbiotech Adjusts Rights Offering Schedule (Payment and Listing Dates Delayed)

 
EXCH
ADBIOTECH
★

Postponement of Shareholders' Meeting to June 5, 2026

 
MATR
ADBIOTECH
★

Adbiotech Self-Convertible Bond Sale Final Payment Date Changed to July 3, 2026